Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Waste Manag ; 113: 312-318, 2020 Jul 15.
Article in English | MEDLINE | ID: mdl-32570156

ABSTRACT

An increasing number of states and municipalities are choosing to reduce plastic litter by replacing plastic items, particularly single-use ones, with same-use products manufactured from compostable plastics. This study investigated the formation and persistence of compostable film microplastic particles (CFMPs) from ultra-thin compostable carrier bags in soil under laboratory conditions, and the potential impact of CFMPs on Aspergillus flavus populations in the soil. During a 12-month incubation period, compostable film samples in soils with small, medium or large populations of indigenous A. flavus, underwent 5.9, 9.8, and 17.1% reduction in total surface area, respectively. Despite the low levels of deterioration, the number of CFMPs released increased steadily over the incubation period, particularly fragments with size < 0.05 mm. Up to 88.4% of the released fragments had associated A. flavus and up to 68% of isolates from CFMPs produced aflatoxins. A. flavus levels associated with CFMPs increased rapidly during the initial part of the 12-month incubation period, whereas the percent aflatoxigenicity continued to increase even after A. flavus density leveled off later. During 12 months incubation, A. flavus DNA amounts recovered from CFMPs increased in soils with all levels of indigenous A. flavus, with the largest increases (119.1%) occurring in soil containing the lowest indigenous A. flavus. These results suggest that burying compostable film in soil, or application of compost containing CFMPs, may reduce soil quality and increase risk of adverse impacts from elevated aflatoxigenic A. flavus populations in soil.


Subject(s)
Aspergillus flavus , Biodegradable Plastics , Microplastics , Soil , Soil Microbiology
2.
J Control Release ; 272: 39-53, 2018 02 28.
Article in English | MEDLINE | ID: mdl-29305922

ABSTRACT

Gold nanoparticles (AuNPs) have attracted great attention in biomedical fields due to their unique properties. However, there are few reports on clinical trial of these nanoparticles. In vivo, AuNPs face complex biological fluids containing abundant proteins, which challenge the prediction of their fate that is known as "bio-identity". These proteins attach onto the AuNPs surface forming protein corona that makes the first step of nano-bio interface and dictates the subsequent AuNPs fate. Protein corona formation even stealth active targeting effect of AuNPs. Manipulating the protein corona identity based on the researcher goal is the way to employ corona to achieve maximum effect in therapy or other applications. In this review, we provide details on the biological identity of AuNPs under various environmental- and/or physiological conditions. We also highlight how the particular corona can direct the biodistribution of AuNPs. We further discuss the strategies available for controlling or reducing corona formation on AuNPs surface and achieving desired effects using AuNPs in vivo by engineering protein corona on their surface.


Subject(s)
Gold , Metal Nanoparticles , Protein Corona , Animals , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...